Saturday 17 October 2026
Export CALC’s income statement to Excel — free account
CalciMedica Inc.
CALC Healthcare Biotechnology
In the quarter to June 2026, EPS fell 12.5%, free cash flow grew 31.4% and total debt rose 8.24%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.07
0.01
−0.93%
Follow CALC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
4.04 | 3.58 | 1.61 | 5.58 |
Net Debt/EBITDA |
0.92 | 0.76 | 0.26 | 2.35 | |
Debt/Assets |
59.68% | 71.37% | 77.83% | 47.17% | |
Debt/Equity |
(33.21) | (1.46) | (6.07) | 1.67 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.61 | 0.45 | (0.98) | 0.60 | |
Capex/Depreciation |
(0.67) | (1.20) | 0.00 | 6.00 | |
Interest Coverage |
(17.23) | (13.49) | (17.59) | (12.34) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.59) | (1.62) | (1.53) | (1.34) | |
Cash per Share |
4.67 | 4.34 | 2.58 | 5.44 | |
Shareholders Equity per Share |
(0.09) | (2.21) | (0.35) | 1.61 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.09) | (2.21) | (0.35) | 1.61 | |
Free Cash Flow |
(4.79) | (4.86) | (4.86) | (4.58) | |
Working Capital |
11.17 | 9.75 | 3.24 | 15.97 | |
Capital Expenditures |
(0.01) | (0.01) | — | 0.04 | |
Net Current Asset Value |
(0.33) | (6.70) | (1.16) | 5.47 | |
| Other line items | |||||
Quick Ratio |
3.83 | 3.44 | 1.54 | 5.33 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.58) | (1.62) | (1.53) | (1.35) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.01 | |
Average Payables |
1.33 | 1.58 | 1.85 | 1.99 | |
Average Assets |
15.56 | 16.69 | 16.98 | 19.29 | |
Average Common Equity |
4.38 | 3.88 | 4.89 | 5.81 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 |
Columns are period end dates